ENO1 and colorectal carcinoma: Using in vitro and in vivo assays, we provide evidence that exosomal LINC00183 is transferred to CRC cells, where it binds to and stabilizes the glycolytic enzyme ENO1 by inhibiting its degradation through the ubiquitin-proteasome pathway.